查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596771

结构生物学和分子建模技术市场：按工具和应用分类 - 全球预测 2025-2030

Structural Biology & Molecular Modeling Techniques Market by Tools (Databases, SaaS & Standalone Modeling, Visualization & Analysis), Application (Drug Development, Drug Discovery) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年结构生物学和分子建模技术市场价值为93.9亿美元，预计2024年将达到111亿美元，复合年增长率为18.34%，到2030年将达到305.2亿美元。

结构生物学和分子建模对于在原子层面上理解生物过程至关重要，为药物发现研发、基因研究和生物技术提供重要见解。我们使用 X 射线结晶结构分析、核磁共振波谱和冷冻电子显微镜等先进技术来视觉化聚合物的结构，并使用分子动力学模拟和同源建模等计算科学方法来了解分子的行为。这些技术对于製药主要企业的药物设计和优化、学术机构的综合生物学研究以及生物技术公司的新型治疗策略的开发至关重要。

主要市场统计
基准年[2023] 93.9亿美元
预测年份 [2024] 111亿美元
预测年份 [2030] 305.2亿美元
复合年增长率（%） 18.34%

结构生物学和分子建模市场主要是由对标靶治疗和个人化医疗的需求不断增长、需要先进研究方法的疾病日益复杂以及成像和计算技术的技术进步所推动的。潜在的机会包括用于预测建模的人工智慧和机器学习的整合、用于增强资料共用和协作的云端基础的工具的扩展，以及需要详细结构分析的生技药品和生物仿製药的增长。然而，设备高成本、资料解释复杂以及对高技能人员的需求等挑战可能会限制市场成长。

创新机会比比皆是，包括开发具有成本效益的技术、自动化资料处理和分析管道，以及扩大农业生物技术和环境科学等非製药领域的应用。该市场的特点是快速发展，需要不断适应和投资研发才能保持竞争力。对公司的建议包括优先考虑战略伙伴关係、专注于缩小技能差距的培训计划以及投资于能够满足不断变化的科学需求的可扩展技术。儘管存在这些障碍，创新治疗方法设计中分子建模的范围正在扩大，并且在现代实验室中至关重要，为成长和发展开闢了广阔的前景。

市场动态：快速发展的结构生物学和分子建模技术市场的关键市场洞察

结构生物学和分子建模技术市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 由于获得性抗药性导致慢性病增加
    • 由于高药物损耗率和药物开发的后期临床试验导致需求增加
    • 透过使用预测软体降低药物失败的可能性
  • 市场限制因素
    • 低度开发国家设备高成本且缺乏足够的设备
  • 市场机会
    • 透过开发有效识别新先导化合物的数学模型进行新技术创新
    • 透过生物医学研究增加优化药物发现流程的研发
  • 市场挑战
    • 缺乏熟练的专业人员

波特的五力：驾驭结构生物学与分子建模技术市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对结构生物学和分子建模技术市场的影响

外部宏观环境因素在塑造结构生物学和分子建模技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解结构生物学/分子建模技术市场的竞争状况

结构生物学和分子建模技术市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵结构生物学与分子建模技术市场供应商绩效评估

FPNV定位矩阵是评估结构生物学和分子建模技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划结构生物学和分子建模技术市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，结构生物学和分子建模技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病发生率增加和抗药性获得
      • 由于药物开发和后期临床试验中药物停药率较高，需求不断增加。
      • 使用预测软体可降低药物失败的可能性
    • 抑制因素
      • 开发中国家的设备相对昂贵且缺乏足够的设施
    • 机会
      • 透过开发经过检验的数学模型来识别新的线索进行新的创新
      • 透过生物医学研究优化药物发现过程的进展
    • 任务
      • 缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按工具分類的结构生物学与分子建模技术市场

  • 资料库
  • SaaS 与独立建模
    • 抗体
    • 同源建模
    • 混合
    • 分子动力学
    • 线
  • 视觉化和分析

第七章结构生物学与分子建模技术市场：依应用分类

  • 药物开发
  • 药物发现

第八章北美和南美结构生物学和分子建模技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区结构生物学与分子建模技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的结构生物学和分子建模技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Acellera Ltd.
  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • Bruker Corporation
  • Chemical Computing Group ULC
  • Dassault Systemes
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD8984FF

The Structural Biology & Molecular Modeling Techniques Market was valued at USD 9.39 billion in 2023, expected to reach USD 11.10 billion in 2024, and is projected to grow at a CAGR of 18.34%, to USD 30.52 billion by 2030.

Structural biology and molecular modeling are pivotal to understanding biological processes at an atomic level, offering vital insights for drug discovery and development, genetic research, and biotechnology. The scope encompasses the use of advanced techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy for visualizing macromolecular structures, complemented by computational methods like molecular dynamics simulations and homology modeling to predict molecular behavior and interactions. These techniques are crucial for pharmaceutical companies in drug design and lead optimization, academic institutions for comprehensive biological research, and biotech firms for developing novel therapeutic strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 9.39 billion
Estimated Year [2024] USD 11.10 billion
Forecast Year [2030] USD 30.52 billion
CAGR (%) 18.34%

The market for structural biology and molecular modeling is primarily driven by the increasing demand for targeted therapies and personalized medicine, the complexity of diseases necessitating advanced research approaches, and technological advancements in imaging and computational techniques. Potential opportunities lie in the integration of AI and machine learning for predictive modeling, expansion of cloud-based tools for enhanced data sharing and collaboration, and the growth of biologics and biosimilars demanding detailed structural analysis. However, challenges like high costs of equipment, the complexity of data interpretation, and the need for highly skilled personnel can restrict market growth.

Innovation opportunities are abundant in developing cost-effective technologies, automating data processing and analysis pipelines, and expanding applications in non-pharmaceutical sectors such as agricultural biotechnology and environmental sciences. The market is characterized by rapid advancements requiring continuous adaptation and investment in R&D to maintain competitiveness. Recommendations for businesses include prioritizing strategic partnerships, focusing on training programs to bridge the skill gap, and investing in scalable technologies that can cater to evolving scientific needs. Despite the barriers, the expanding scope of molecular modeling in innovative therapeutic design and its indispensability in modern research laboratories present substantial prospects for growth and development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Structural Biology & Molecular Modeling Techniques Market

The Structural Biology & Molecular Modeling Techniques Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of chronic diseases coupled with acquired drug resistance property
    • Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
    • Reduced probability of drug failure with use of prediction software
  • Market Restraints
    • Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
  • Market Opportunities
    • Emerging technological innovations with the development of validated mathematical models for identification of novel leads
    • Increasing developments in optimization of drug discovery process with biomedical research
  • Market Challenges
    • Dearth of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Structural Biology & Molecular Modeling Techniques Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Structural Biology & Molecular Modeling Techniques Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Structural Biology & Molecular Modeling Techniques Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Structural Biology & Molecular Modeling Techniques Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Structural Biology & Molecular Modeling Techniques Market

A detailed market share analysis in the Structural Biology & Molecular Modeling Techniques Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Structural Biology & Molecular Modeling Techniques Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Structural Biology & Molecular Modeling Techniques Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Structural Biology & Molecular Modeling Techniques Market

A strategic analysis of the Structural Biology & Molecular Modeling Techniques Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Structural Biology & Molecular Modeling Techniques Market, highlighting leading vendors and their innovative profiles. These include Acellera Ltd., Agilent Technologies, Inc., Biomax Informatics AG, Bruker Corporation, Chemical Computing Group ULC, Dassault Systemes, Illumina, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tools, market is studied across Databases, SaaS & Standalone Modeling, and Visualization & Analysis. The SaaS & Standalone Modeling is further studied across Antibodies, Homology Modeling, Hybrid, Molecular Dynamics, and Threading.
  • Based on Application, market is studied across Drug Development and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of chronic diseases coupled with acquired drug resistance property
      • 5.1.1.2. Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
      • 5.1.1.3. Reduced probability of drug failure with use of prediction software
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological innovations with the development of validated mathematical models for identification of novel leads
      • 5.1.3.2. Increasing developments in optimization of drug discovery process with biomedical research
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Structural Biology & Molecular Modeling Techniques Market, by Tools

  • 6.1. Introduction
  • 6.2. Databases
  • 6.3. SaaS & Standalone Modeling
    • 6.3.1. Antibodies
    • 6.3.2. Homology Modeling
    • 6.3.3. Hybrid
    • 6.3.4. Molecular Dynamics
    • 6.3.5. Threading
  • 6.4. Visualization & Analysis

7. Structural Biology & Molecular Modeling Techniques Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Drug Discovery

8. Americas Structural Biology & Molecular Modeling Techniques Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Structural Biology & Molecular Modeling Techniques Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Structural Biology & Molecular Modeling Techniques Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acellera Ltd.
  • 2. Agilent Technologies, Inc.
  • 3. Biomax Informatics AG
  • 4. Bruker Corporation
  • 5. Chemical Computing Group ULC
  • 6. Dassault Systemes
  • 7. Illumina, Inc.
  • 8. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET RESEARCH PROCESS
  • FIGURE 2. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET DYNAMICS
  • TABLE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY THREADING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023